Clinical (age, sex, treatment), histological (necrosis and/or microvascular proliferation) and molecular (CNS-tumour classifier class, CNV load and CDKN2A/B HD) characteristics of patients within each CGC class are presented in Supplementary Table 1. Here, CDKN2A is linked to central nervous system neoplasm.